The European sleep-wake disorder market is estimated to grow at a CAGR of 5.5% during the forecast period. The key driving factor of the market in the region is the increasing sleep-wake disorders due to various behavioral health issues of the population which is expected to promote the demand for sleep-wake disorder treatment solutions, thereby promoting the growth of the market in the near future. According to the NCBI, about three-quarters of depressed patients have insomnia symptoms and hypersomnia. Moreover, there are various organizations that are promoting research on sleep disorders that further contributes to the market. For instance, The European Sleep Research Society is an international non-profit organization that promotes research on sleep and related areas, to improve the care for patients with sleep disorders and to facilitate the distribution of information regarding sleep medicine and sleep research.
To Request a Sample of our Report on European Sleep-Wake Disorder Market: https://www.omrglobal.com/request-sample/european-sleep-wake-disorder-market
Europe consists of numerous key economies consisting of UK, Germany, Italy, Spain, and France among various others. The rest of Europe consists of countries such as Denmark, Belgium, Iceland, the Netherlands, Sweden, Russia and so on. The healthcare expenditure in these countries is also increasing yearly. The increase in the healthcare structure of these countries and the progressive government policies in the healthcare of these countries is focusing on the sleep-wake disorder treatment and research. The Swiss Society for Sleep Research, Sleep Medicine and Chronobiology (SSSSC) together include basic science and clinical sleep researchers, chronobiologists and sleep clinicians to promote and stimulate collaboration.
The market is segmented on the basis of type and treatment. Based on type, the market is sub-segmented into insomnia, hypersomnia, sleep apnea, circadian rhythm disorders, and others. Sleep apnea holds the largest market share during the forecast period. On the basis of treatment, the market is divide into therapies, drugs, and devices. The sleep-wake disorder devices segment is estimated to hold the largest market share during the forecast period, followed by medications.
(Get 15% Discount on Buying this Report)
A full Report of European Sleep-Wake Disorder Market is Available @ https://www.omrglobal.com/industry-reports/european-sleep-wake-disorder-market
European Sleep-Wake Disorder Market Segmentation
By Type
- Insomnia
- Hypersomnia
- Circadian Rhythm Disorders
- Others
By Treatment
- Therapies
- Drugs
- Devices
Regional Analysis
- UK
- Germany
- Italy
- Spain
- France
Rest of Europe
Company Profiles
- Arena Pharmaceuticals, Inc.
- Acorda Therapeutics, Inc.
- Jazz Pharmaceuticals Inc.
- Koninklijke Philips N.V.
- LivaNova PLC
- Medtronic PLC
- Natus Medical Inc.
- Pfizer Inc.
- Sanofi SA
- SomnoMed AG
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
